Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,825,236
+$1,461,596 QoQ
Shares Held
16,763
+61.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#270
of 768 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 20262Xideas AG holds $6,280,965 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (45.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
370,389 | $3,455,729 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
16,763 | $2,825,236 |
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,825,236 | 16,763 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,363,640 | 10,351 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,168,100 | 29,388 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,130,882 | 50,797 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,523,415 | 67,813 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,019,495 | 72,509 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,880,957 | 109,018 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||